TrakCel & McKesson partner to help commercialize gene & cell therapy
By Nikita Chaurasia  Date: 2019-09-13

TrakCel & McKesson partner to help commercialize gene & cell therapy
  • The combination of these two product suites is designed specifically for the growing number of developers that are nearing the commercial launch of gene and cell therapies.
  • The integrated platform allows the product scale-up towards market delivery including automatic product-specific workflow scheduling across multiple care team members and supply chain partners.

McKesson, a leading provider of patient access support, third-party logistic (3PL) services as well as specialty pharmacy solutions, and TrakCel, software developing firm for gene and cell therapy orchestration and supply chain tracking systems, reportedly announced a collaboration to help late-stage developers of gene and cell therapy.

The collaboration will combine both companies’ patient access services and supply chain tracking to allow a more effective path for the industry players to develop next-gen commercial therapies.

Integrating TrakCel’s personalized drug orchestration software and data tracking system with the capabilities of McKesson’s current high-touch platform for patients, as well as both the companies’ support and expertise, will give an end-to-end solution for the gene and cell therapy industry to manage the entirety of the therapeutic supply chain.

McKesson and TrakCel would start by developing a basic solution design. Both these integrated solutions will further be offered to individual company clients which would then benefit specifically from this combined solution.

The combination of these two product suites is particularly designed for the growing number of developers that are approaching commercial launch of their gene and cell therapies. The integrated platform allows the product scale-up towards market delivery.

This also involves automated scheduling of product-centric workflows across numerous care team members and supply chain partners, and a validated tracking of chain-of-identity to ensure delivery of the right drug product. These capabilities guarantee that the patient gets the right, uncompromised treatment at the correct time.

Layne Martin, VP/GM of Specialty Distribution Solutions at McKesson Life Sciences stated that the integrated system would help manufacturers and prescribers work together in a seamless manner to ensure that right patient always gets the right therapeutic product and at the correct time.

Source credit: https://www.businesswire.com/news/home/20190911005059/en/McKesson-TrakCel-Launch-Innovative-Collaboration-Support-Commercialization

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Microsoft makes ‘carbon negative’ pledge to reach near zero emissions
Microsoft makes ‘carbon negative’ pledge to reach near zero emissions
By Nikita Chaurasia

Microsoft, a tech giant based in Redmond, Washington, has reportedly announced plans to go “carbon negative” by reducing carbon footprint from the atmosphere, by 2030. The technological company is placing strong emphasis on removing more...

Nissan, Renault denounce split rumors following Chairman Ghosn’s exit
Nissan, Renault denounce split rumors following Chairman Ghosn’s exit
By Nikita Chaurasia

The automakers ensure that the alliance was not under the danger of being dissolved. Renault shares have hit six years low after the split report. Automotive giants Nissan and Renault have recently denied reports of a possible split that resulte...

Visa to take over fintech firm ‘Plaid’ in $5.3 Bn acquisition deal
Visa to take over fintech firm ‘Plaid’ in $5.3 Bn acquisition deal
By Nikita Chaurasia

Visa, a financial services corporation, is reportedly acquiring Plaid, a start-up company based in San Francisco, in a deal worth $5.3 Bn. It is a long-term play that would position Visa as a leading company in the next decade and help Plaid scale it...

Dupont to invest $28Mn to produce advanced chip materials in S.Korea
Dupont to invest $28Mn to produce advanced chip materials in S.Korea
By Nikita Chaurasia

The company plans to develop a new facility in South Korea that would help reduce its dependency on Japan for semiconductor products. As Japan’s diplomatic relations with South Korea sour up, U.S. chemical company DuPont has revealed plans to...

Spotify unveils new streaming ad insertion tech to monetize podcasts
Spotify unveils new streaming ad insertion tech to monetize podcasts
By Nikita Chaurasia

Spotify Technology S.A., a Sweden based international media services provider, has reportedly announced a new podcast advertising technology called SAI (Streaming Ad Insertion) at the Consumer Electronics Show in Las Vegas. This new technology, for ...